Sarfaraz S, Afaq F, Adhami VM, Malik A, Siddiqui I, Mukhtar H (2007) Cannabinoid receptor

agonist WIN-55,212-2 inhibits angiogenesis, metastasis and tumor growth of androgen-

sensitive prostate cancer cell CWR22R v1 xenograft in athymic nude mice. Proc Am Assoc

Cancer Res 48:521

Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HHQ (1999) Identification and

cloning of three novel human G protein-coupled receptor genes GPR52, Psi GPR53 and GPR55:

GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64:193–198

Schuelert N, McDougall JJ (2011) The abnormal cannabidiol analogue O-1602 reduces nociception

in a rat model of acute arthritis via the putative cannabinoid receptor GPR55. Neurosci Lett 500:

72–76

Shen M, Piser TM, Seybold VS (1996) Cannabinoid receptor agonists inhibit glutamatergic

synaptic transmission in rat hippocampal cultures. J Neurosci 16(14):4322–4334

Starowicz K, Malek N, Przewlocka B (2013) Cannabinoid receptors and pain. Wiley Interdiscip

Rev Membr Transp Signal 2:121–132

Steffens S, Veillard NR, Arnaud C (2005) Low dose oral cannabinoid therapy reduces progression

of atherosclerosis in mice. Nature 434:782–786

Sugamura K, Sugiyama S, Nozaki T (2009) Activated endocannabinoid system in coronary artery

disease and anti-inflammatory effects of cannabinoid 1 receptor blockade on macrophages.

Circulation 119:28–36

Szabo B, Wallmichrath I, Mathonia P et al (2000) Cannabinoids inhibit excitatory neurotransmis-

sion in the substantia nigra pars reticulata. Neuroscience 97(1):89–97

Tomko A, O’Leary L, Trask H, Achenbach JC, Hall SR, Goralski KB et al (2019) Antitumor

activity of abnormal cannabidiol and its analog O-1602 in taxol-resistant preclinical models of

breast cancer. Front Pharmacol 10:1124

Torres S, Lorente M, Rodríguez-Fornés F, Hernández-Tiedra S, Salazar M, García-Taboada E et al

(2011) A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol

Cancer Ther 10(1):90–103

Touwn M (1981) The religious and medicinal uses of cannabis in China, India and Tibet. J

Psychoactive Drugs 13(1):23–34

Ungerleider JT, Andyrsiak T, Fairbanks L et al (1987) Delta-9-THC in the treatment of spasticity

associated with multiple sclerosis. Adv Alcohol Subst Abuse 7(1):39–50

Vachon L, FitzGerald MX, Solliday NH, Gould IA, Gaensler EA (1973) Single-dose effects of

marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. N

Engl J Med 288(19):985–989

Vaney C, Heinzel-Gutenbrunner M, Jobin P et al (2004) Efficacy, safety and tolerability of an orally

administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a

randomized, double-blind, placebo-controlled, crossover study. Mult Scler 10(4):417–424

Vincent BJ, McQuiston DJ, Einhorn LH, Nagy CM, Brames MJ (1983) Review of cannabinoids

and their antiemetic effectiveness. Drugs 25(Suppl. 1):52–62

Walsh D, Nelson KA, Mahmoud FA (2003) Established and potential therapeutic applications of

cannabinoids in oncology. Support Care Cancer 11:137–143

Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, Greasley PJ (2009) The putative cannabinoid

receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U

S A 106:16511–16516

Xian XS, Park H, Cho YK, Lee IS, Kim SW, Choi MG et al (2010) Effect of a synthetic

cannabinoid agonist on the proliferation and invasion of gastric cancer cells. J Cell Biochem

110(2):321–332

Xian XS, Park H, Choi MG, Park JM (2013) Cannabinoid receptor agonist as an alternative drug in

5-fluorouracil-resistant gastric cancer cells. Anticancer Res 33(6):2541–2547

Yuan M, Kiertscher SM, Cheng Q (2002) Delta 9-tetrahydrocannabinol regulates Th1/Th2 cytokine

balance in activated human T cells. J Neuroimmunol 133:124–131

Zoerner AA, Stichtenoth DO, Engeli S, Batkai S, Winkler C, Schaumann F (2011) Allergen

challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma. Clin

Pharmacol Ther 90(3):388–391

12

Emerging Role of Cannabinoid System Modulators in Treatment of Cancer

201